Related references
Note: Only part of the references are listed.A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
Nobutoshi Ando et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Efficacy and safety of docetaxel/cisplatin/5-fluorouracil preoperative combination chemotherapy in esophageal cancer patients with extended lymph node metastases
Tsuyoshi Tanaka et al.
ESOPHAGUS (2012)
Comprehensive Registry of Esophageal Cancer in Japan, 2004
Soji Ozawa et al.
ESOPHAGUS (2012)
Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma
Tak Yun et al.
BMC CANCER (2011)
Induction Chemotherapy with Docetaxel/Cisplatin/5-Fluorouracil for Patients with Node-Positive Esophageal Cancer
Masayuki Watanabe et al.
DIGESTION (2011)
Assessment of a scoring system for predicting complications after esophagectomy
M. K. Ferguson et al.
DISEASES OF THE ESOPHAGUS (2011)
Validation of a Nomogram Predicting Complications After Esophagectomy for Cancer
Brechtje A. Grotenhuis et al.
ANNALS OF THORACIC SURGERY (2010)
Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study
Yoshihiro Tanaka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Phase I/II Study of Docetaxel/Cisplatin/Fluorouracil Combination Chemotherapy Against Metastatic Esophageal Squamous Cell Carcinoma
Hiroaki Takahashi et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie
S. Lorenzen et al.
ANNALS OF ONCOLOGY (2009)
Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma
Youling Gong et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram
Sjoerd M. Lagarde et al.
ANNALS OF THORACIC SURGERY (2008)
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
Marshall R. Posner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Long-term results of RTOG trial 8911 (USA intergroup 113): A random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer
David P. Kelsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Second-line combination chemotherapy with docetaxel for cisplatin-pretreated refractory metastatic esophageal cancer: A preliminary report of initial experience
Toshiaki Tanaka et al.
CHEMOTHERAPY (2007)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
BH Burmeister et al.
LANCET ONCOLOGY (2005)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study - JCOG9204
N Ando et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
